Ken-ichi Miyamoto
Department of Hospital Pharmacy
School of Medicine
Kanazawa University
Kanazawa
Japan
Name/email consistency: high
- Phosphodiesterase 4 inhibitor rolipram potentiates the inhibitory effect of calcitonin on osteoclastogenesis. Miyamoto, K., Nishioka, T., Waki, Y., Nomura, M., Katsuta, H., Yokogawa, K., Amano, H. J. Bone Miner. Metab. (2006)
- Serum aminotransferase activity as a predictor of clearance of drugs metabolized by CYP isoforms in rats with acute hepatic failure induced by carbon tetrachloride. Yokogawa, K., Watanabe, M., Takeshita, H., Nomura, M., Mano, Y., Miyamoto, K. Int. J. Pharm (2004)
- Prostaglandin E2-mediated anabolic effect of a novel inhibitor of phosphodiesterase 4, XT-611, in the in vitro bone marrow culture. Miyamoto, K., Suzuki, H., Yamamoto, S., Saitoh, Y., Ochiai, E., Moritani, S., Yokogawa, K., Waki, Y., Kasugai, S., Sawanishi, H., Yamagami, H. J. Bone Miner. Res. (2003)